Innovative Medicines for Tuberculosis Foundation (iM4TB)
Lausanne, Switzerland
Purpose
to accelerate the development of the new TB drug candidate PBTZ169, that has a strong potential, in combination with other anti-TB agents, to shorten and simplify the treatment of multidrug-resistant- and extensively drug-resistant tuberculosis
Division
Global Health
Date
February 2015
Region Served
GLOBAL
Committed amount
$744,728
Grant topic
Tuberculosis
Duration (months)
19
Grantee location
Lausanne, Switzerland
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.